Abstract
Objectives This review aimed to evaluate previous studies using Near-infrared spectroscopy (NIRS) in dementia by summarising the results, determining the consensus in the literature, and delineating if, and how, NIRS experimental and analysis methods may be improved for future studies in dementia.
Methods Three databases (PsychINFO, Medline, Embase) were searched for original research studies using NIRS in dementia and prodromal disease stages. We included both observational and randomised control trials, and studies published in English. Animal studies, conference abstracts, and reviews were excluded.
Results From 759 identified records, 80 studies using NIRS in dementia and prodromal populations across a range of activation tasks testing memory (28), word retrieval (22), and motor (7) and visuo-spatial function (4), as well as in the resting state (29) were evaluated. Across these cognitive domains, dementia patients generally showed a blunted haemodynamic response, often localised to frontal regions of interest, and a lack of task-appropriate frontal lateralisation. Prodromal stages, such as Mild Cognitive Impairment, revealed mixed results and were associated with either diminished responses or hyperactivity, accompanied by reduced cognitive function, the latter suggesting a possible compensatory neural response which is not present at the dementia stage.
Conclusion There is clear evidence of alterations in brain oxygenation in both dementia and prodromal stages across a range of cognitive domains and in the resting state, indicating an ability of NIRS to distinguish dementia from healthy ageing, or at-risk populations. A consensus as to the nature of these changes, however, is difficult to reach due to a lack of standardisation in optical techniques and processing methods. Further studies are required exploring more naturalistic settings and in a wider range of dementia subtypes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data in the present work is available online.
